Cargando…
PAPPA2 as a Therapeutic Modulator of IGF-I Bioavailability: in Vivo and in Vitro Evidence
CONTEXT: Pregnancy-associated plasma protein A2 (PAPPA2) is a protease that cleaves IGF-binding protein (IGFBP)-3 and IGFBP-5, liberating free IGF-I. Five patients from two families with genetic mutations in PAPPA2 presented with growth retardation, elevated total IGF-I, and IGFBP-3 but decreased fr...
Autores principales: | Andrew, Melissa, Liao, Lihong, Fujimoto, Masanobu, Khoury, Jane, Hwa, Vivian, Dauber, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009608/ https://www.ncbi.nlm.nih.gov/pubmed/29942928 http://dx.doi.org/10.1210/js.2018-00106 |
Ejemplares similares
-
OR07-5 A Cross-Sectional Study of IGF-I Bioavailability through Childhood: Associations with PAPP-A2 and Anthropometric Data
por: Fujimoto, Masanobu, et al.
Publicado: (2019) -
Novel Modulators of the Growth Hormone - Insulin-Like Growth Factor Axis: Pregnancy-Associated Plasma Protein-A2 and Stanniocalcin-2
por: Fujimoto, Masanobu, et al.
Publicado: (2017) -
Placental expression of PAPPA, PAPPA-2 and PLAC-1 in pregnacies is associated with FGR
por: Sifakis, Stavros, et al.
Publicado: (2018) -
Recombinant IGF-1 Induces Sex-Specific Changes in Bone Composition and Remodeling in Adult Mice with Pappa2 Deficiency
por: Rubio, Leticia, et al.
Publicado: (2021) -
SUN-054 Genetic Studies of Height-Associated Protein Expression Levels in Childhood
por: Fujimoto, Masanobu, et al.
Publicado: (2020)